Frankenius Equity AB
SEC insider (Form 3/4/5 filer). CIK 0001988262. 10% Owner at TriSalus Life Sciences, Inc. (TLSI). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2025. Located in BORAS.
Companies Frankenius Equity AB has filed insider reports for
- TriSalus Life Sciences, Inc. (TLSI): 10% Owner
Frankenius Equity AB
CIK: 0001988262
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TLSI
TriSalus Life Sciences, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 31, 2025TLSI
TriSalus Life Sciences, Inc.
ConversionDirect759K shares- - Feb 10, 2025TLSI
TriSalus Life Sciences, Inc.
OtherDirectSeries A Convertible Preferred Stock
205.9K shares- - Dec 17, 2024TLSI
TriSalus Life Sciences, Inc.
PurchaseDirect63K shares at avg. $3.97$250K
1-3 of 3 transactions